Trial Profile
A Feasibility Study of Vorinostat (SAHA) Combined With Isotretinoin and Chemotherapy in Infants With Embryonal Tumors of the Central Nervous System
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2022
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary) ; Carboplatin; Cisplatin; Cyclophosphamide; Etoposide phosphate; Isotretinoin; Thiotepa; Vincristine
- Indications Medulloblastoma; Primitive neuroectodermal tumours; Rhabdoid tumour
- Focus Adverse reactions; Therapeutic Use
- 12 Jan 2022 Status changed from active, no longer recruiting to completed.
- 16 May 2018 Planned primary completion date changed from 30 Dec 2017 to 30 Dec 2018.
- 04 May 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2017.